Diagnosing and Managing Schizophrenia: Practical Strategies for the Federal Healthcare Professional
Time to complete: 60 Minutes
- 1.0 AMA PRA Category 1 Credit(s)™
- 1.0 California Board of Registered Nursing (CBRN)
- 1.0 Accreditation Council for Pharmacy Education (ACPE)
Overview: This activity addresses important issues in the identification, diagnosis, and management of schizophrenia in patients within the federal healthcare system, which includes active-duty servicemembers, Veterans, and others. It is designed to increase the awareness of schizophrenia as a possible diagnosis among other common conditions in this patient population, assist with the development of treatment plans based on current guideline recommendations, and guide the modification of treatment regimens based on patient response, adverse effects, adherence concerns, and other treatment challenges.
Mark Olfson, MD, MPH
William V. Bobo, MD, MPH
Robert A. Rosenheck, MD
This activity has been approved for AMA PRA Category 1 Credit™.
This activity is supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.